Clinical Trial: HealtheTech Lifestyle Program

This study is no longer recruiting patients.

Sponsors and Collaborators: The Cooper Institute
Information provided by: The Cooper Institute Identifier: NCT00146510


The purpose of the study is to determine the efficacy of resting metabolic rate (RMR) using BodyGem and BalanceLog in helping overweight and obese individuals manage their weight.
Condition Intervention Phase
Health behavior
Patient Compliance
 Behavior: HealtheLifestyle Program
 Behavior: step counters with monthly feedback on logs
Phase I

MedlinePlus consumer health information 

Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Single Blind, Dose Comparison, Single Group Assignment, Efficacy Study

Official Title: HealtheLifestyle Behavioral Intervention Clinical Trial

Further Study Details: 
Primary Outcomes: HealtheLifestyle participants will have greater weight loss
Secondary Outcomes: HealtheLifestyle Program will increase efficacy of products
Expected Total Enrollment:  130

Study start: March 2004;  Study completion: February 2006
Last follow-up: February 2006;  Data entry closure: February 2006

The study plans are to develop and test the efficacy of a practical, structured, and time-limited behavioral intervention (HealtheLifestyle Program) as a supplement to standard HealtheTech products. Approximately 130 participants will be recruited and randomized to either the HealtheTech Program (focusing on calorie and exercise goals using the BalanceLog for tracking), the HealtheLifestyle Program (using step counters, monthely email letters and calls providing information on activity, nutrition, and weight loss), or a delayed treatment program (after 3 months undergo the intervention above).


Ages Eligible for Study:  18 Years   -   60 Years,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers


Inclusion Criteria: healthy adult men and women, 18-60 years -

Exclusion Criteria: not currently participating in a structured diet or exercise program


Location Information

      The Cooper Institute, Dallas,  Texas,  75230,  United States

Study chairs or principal investigators

Heather Kitzman, MPH,  Study Director,  The Cooper Institute   

More Information

Study ID Numbers:  CI-0126
Last Updated:  September 6, 2005
Record first received:  September 2, 2005 Identifier:  NCT00146510
Health Authority: United States: Institutional Review Board processed this record on 2005-09-13


Common Treatments

[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Follow Us